文献速递免疫规划妇幼与学校卫生

产科照护提供者对未来B族链球菌疫苗的接受度——三国定性研究

Maternity care provider acceptance of a future Group B Streptococcus vaccine - A qualitative study in three countries.
PubMed 文献 · Vaccine · 2023-02-18

该定性研究在美国、爱尔兰和多米尼加共和国访谈了38名产科医生、18名全科医生和14名助产士,探讨产科照护提供者对引入B族链球菌(GBS)疫苗的态度。提供者态度不一,从热情到对疫苗必要性存疑,受感知额外获益和孕期疫苗安全信心影响。作者建议针对性教育应强调安全性数据及疫苗相对于当前策略的潜在获益。

要点

  • 三国38名产科医生、18名全科医生和14名助产士参与半结构化访谈。
  • 提供者对假设性GBS疫苗态度不一,从热情到对疫苗必要性存疑。
  • 态度受感知额外获益和孕期疫苗安全信心影响,知识经验因地区和提供者类型而异。

核心结论

  • 产科照护提供者关注GBS管理,存在利用其态度和信念支持强烈推荐GBS疫苗的机会。
  • 不同地区和不同提供者类型对GBS知识及当前预防策略局限性的了解存在差异。
  • 针对产前提供者的针对性教育应侧重于强调安全性数据以及接种相对于当前策略的潜在获益。

研究设计与样本

  • 定性研究,在三个国家(美国、爱尔兰、多米尼加共和国)对产科照护提供者进行半结构化访谈。
  • 访谈转录并编码主题,采用持续比较法和归纳理论构建得出结论。
  • 共38名产科医生、18名全科医生和14名助产士参与。

主要发现

  • 提供者对假设性GBS疫苗的态度存在变异性,应答从热情到对疫苗必要性存疑。
  • 态度受疫苗相对于当前策略的感知额外获益及对孕期疫苗安全性的信心影响。
  • GBS预防的知识、经验和做法在地理上和提供者类型间存在差异,并影响对GBS疫苗风险获益的评估。

临床怎么用

  • 作者建议针对性教育应侧重于强调安全性数据以及接种相对于当前策略的潜在获益。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There are vaccines in clinical trials that target the bacterium Group B Streptococcus (GBS). When approved, GBS vaccines will be intended for administration to pregnant women to prevent infection in their infants. The success of any vaccine will depend on its' uptake in the population. Experience with prior maternal vaccines, e.g. influenza, Tdap and COVID-19 vaccines, teaches us that acceptance of vaccines, especially if novel, is challenging for pregnant women, and that provider recommendation is a key driver of vaccine uptake. METHODS: This study investigated attitudes of maternity care providers towards the introduction of a GBS vaccine in three countries (the United States (US), Ireland, and the Dominican Republic (DR)) with different GBS prevalence and prevention practices. Semi-structured interviews with maternity care providers were transcribed and coded for themes. The constant comparative method, and inductive theory building were used to develop conclusions. RESULTS: Thirty-eight obstetricians, 18 general practitioners and 14 midwives participated. There was variability in provider attitudes towards a hypothetical GBS vaccine. Responses ranged from enthusiasm to doubts over the need for a vaccine. Attitudes were influenced by perceived additional benefits of a vaccine over current strategy and confidence in the safety of vaccines during pregnancy. Knowledge, experience and approaches to GBS prevention differed geographically and according to provider type, and influenced how participants assessed the risks and benefits of a GBS vaccine. CONCLUSION: Maternity care providers are engaged in the topic of GBS management and there is opportunity to leverage attitudes and beliefs that will support a strong recommendation for a GBS vaccine. However, knowledge of GBS, and of the limitations of current prevention strategies vary among providers in different regions, and between different provider types. Targeted educational efforts with antenatal providers should focus on highlighting safety data the potential benefits of vaccination over current strategies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Geoghegan S, Acosta F, Stephens LC, et al. Maternity care provider acceptance of a future Group B Streptococcus vaccine - A qualitative study in three countries. Vaccine. 2023. PMID: 36803900. doi:10.1016/j.vaccine.2023.02.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。